Type IIb Heat Labile Enterotoxin B Subunit as a Mucosal Adjuvant to Enhance Protective Immunity against H5N1 Avian Influenza Viruses

Human infections with highly pathogenic avian influenza H5N1 viruses persist as a major global health concern. Vaccination remains the primary protective strategy against H5N1 and other novel avian influenza virus infections. We investigated the use of <i>E. coli</i> type IIb heat labile enterotoxin...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Neos Tang, Chun-Yi Lu, Shih-Che Sue, Ting-Hsuan Chen, Jia-Tsrong Jan, Ming-Hsi Huang, Chung-Hsiung Huang, Chung-Chu Chen, Bor-Luen Chiang, Li-Min Huang, Suh-Chin Wu
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2020-11-01
Rangatū:	Vaccines
Ngā marau:	intranasal immunization mucosal adjuvant LTIIb-B5 H5N1 vaccine
Urunga tuihono:	https://www.mdpi.com/2076-393X/8/4/710
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!